(19)
(11) EP 1 470 107 A2

(12)

(88) Date of publication A3:
04.12.2003

(43) Date of publication:
27.10.2004 Bulletin 2004/44

(21) Application number: 03700740.8

(22) Date of filing: 22.01.2003
(51) International Patent Classification (IPC)7C07D 209/80, A61K 31/403, A61P 43/00, C07D 209/88
(86) International application number:
PCT/CA2003/000084
(87) International publication number:
WO 2003/062200 (31.07.2003 Gazette 2003/31)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
Designated Extension States:
AL LT LV MK RO

(30) Priority: 24.01.2002 US 351384 P

(71) Applicant: MERCK FROSST CANADA & CO.
Kirkland, Quebec H9H 3L1 (CA)

(72) Inventors:
  • BERTHELETTE, Carl
    Kirkland, Québec H9H 3L1 (CA)
  • LACHANCE, Nicolas
    Kirkland, Québec H9H 3L1 (CA)
  • LI, Lianhai
    Kirkland, Québec H9H 3L1 (CA)
  • STURINO, Claudio
    Kirkland, Québec H9H 3L1 (CA)
  • WANG, Zhaoyin
    Kirkland, Québec H9H 3L1 (CA)

(74) Representative: Buchan, Gavin MacNicol et al
Merck & Co., Inc.,European Patent Department,Terlings Park,Eastwick Road
Harlow,Essex CM20 2QR
Harlow,Essex CM20 2QR (GB)

   


(54) FLUORO SUBSTITUTED CYCLOALKANOINDOLES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS